These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37005173)

  • 21. Exploring prognostic factors for HER2-positive metastatic breast cancer: a retrospective cohort study in a major Swiss hospital.
    Bringolf L; Pestalozzi B; Fink D; Dedes K
    Swiss Med Wkly; 2016; 146():w14393. PubMed ID: 28102883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival outcomes in unresectable metastatic rectal cancer patients after both primary site resection and chemoradiotherapy: a SEER-based observational study.
    Chen J; Chen H; Zhao F; Wang Z; Liu Q
    Transl Cancer Res; 2022 Jan; 11(1):171-180. PubMed ID: 35261894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival outcomes according to the tumor location and prognostic factor in metastatic rectal cancer: a multicenter retrospective cohort study.
    Unal OU; Akay S; Semiz HS; Keser M; Demir G; Capar ZG; Demirciler E; Yavuzsen T; Degirmencioglu S; Demir B; Oktay E; Gulmez MD; Arayici ME
    Front Oncol; 2024; 14():1363305. PubMed ID: 38947890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upfront primary tumour resection and survival in synchronous metastatic colorectal cancer according to primary tumour location and RAS status: Pooled analysis of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD).
    Benavides M; Gómez-España A; García-Alfonso P; González CG; Viéitez JM; Rivera F; Safont MJ; Abad A; Sastre J; Valladares-Ayerbes M; Carrato A; González-Flores E; Robles L; Salud A; Alonso-Orduña V; Montagut C; Asensio E; Díaz-Rubio E; Aranda E;
    Eur J Surg Oncol; 2022 May; 48(5):1123-1132. PubMed ID: 34872775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: a prospective study.
    Madbouly KM; Abbas KS; Hussein AM
    Am J Surg; 2014 Jun; 207(6):824-31. PubMed ID: 24112666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.
    Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hoerner-Rieber J; König L; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
    J Neurooncol; 2017 Aug; 134(1):205-212. PubMed ID: 28560661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary rectal carcinoma in patients with stage IV resectable disease at diagnosis.
    Pasetto LM; Friso ML; Pucciarelli S; Basso U; Toppan P; Rugge M; Sinigaglia G; Nitti D; Sotti G; Monfardini S
    Anticancer Res; 2007; 27(2):1079-85. PubMed ID: 17465247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment strategy for rectal cancer with synchronous metastasis: 65 consecutive Italian cases from the Bologna Multidisciplinary Rectal Cancer Group.
    Pinto C; Pini S; Di Fabio F; Cuicchi D; Iacopino B; Lecce F; Ercolani G; Rojas Llimpe FL; De Raffele E; Stella F; Di Tullio P; Giaquinta S; Pinna AD; Cola B
    Oncology; 2014; 86(3):135-42. PubMed ID: 24504268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The comparison of oncologic outcomes between metastatic upper tract urothelial carcinoma and urothelial carcinoma of the bladder after cisplatin-based chemotherapy.
    Hsieh MC; Chiang PH; Rau KM; Chen YY; Su YL; Huang CH
    Urol Oncol; 2015 Nov; 33(11):495.e9-495.e14. PubMed ID: 26254698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neoadjuvant chemotherapy and primary-first approach for rectal cancer with synchronous liver metastases.
    Gall TM; Basyouny M; Frampton AE; Darzi A; Ziprin P; Dawson P; Paraskeva P; Habib NA; Spalding DR; Cleator S; Lowdell C; Jiao LR
    Colorectal Dis; 2014 Jun; 16(6):O197-205. PubMed ID: 24344746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does early PET/CT assesment of response to chemotherapy predicts survival in patients with advanced stage non-small-cell lung cancer?
    Ordu C; Selcuk NA; Erdogan E; Angin G; Gural Z; Memis H; Yencilek E; Dalsuna S; Pilanci K
    Medicine (Baltimore); 2014 Dec; 93(28):e299. PubMed ID: 25526475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrospective survival analysis of stage II-III rectal cancer: tumour regression grade, grading and lymphovascular invasion are the only predictors.
    Morini A; Annicchiarico A; Romboli A; Ricco' M; Crafa P; Montali F; Dell'Abate P; Costi R
    ANZ J Surg; 2021 Mar; 91(3):E112-E118. PubMed ID: 33319510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of efficacy between sorafenib and sunitinib as first-line therapy for metastatic renal cell carcinoma and analyze prognostic factors for survival].
    Cai W; Yuan YC; Li MY; Kong W; Dong BJ; Chen YH; Zhang J; Xue W; Huang YR; Zhou LX; Huang JW
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):384-389. PubMed ID: 29860767
    [No Abstract]   [Full Text] [Related]  

  • 34. Prognostic Value of Site-Specific Metastases and Therapeutic Roles of Surgery and Chemotherapy for Patients With Metastatic Renal Pelvis Cancer: A SEER Based Study.
    Chen WK; Wu ZG; Xiao YB; Wang QQ; Yu DD; Cai J; Zhou CF
    Technol Cancer Res Treat; 2021; 20():15330338211004914. PubMed ID: 33929915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of Human Epidermal Growth Factor Receptor-2 in Resected Rectal Cancer.
    Meng X; Huang Z; Di J; Mu D; Wang Y; Zhao X; Zhao H; Zhu W; Li X; Kong L; Xing L
    Medicine (Baltimore); 2015 Nov; 94(47):e2106. PubMed ID: 26632727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A nomogram to predict the prognosis of patients with unresected rectal adenocarcinoma undergoing chemoradiotherapy: a population-based study.
    Liu LL; Sun JD; Xiang ZL
    J Cancer; 2021; 12(16):4745-4761. PubMed ID: 34234846
    [No Abstract]   [Full Text] [Related]  

  • 37. [Real-world study on the efficacy and prognostic predictive biomarker of patients with metastatic non-small cell lung cancer treated with programmed death-1/programmed death ligand 1 inhibitors].
    Zhu WJ; Zhu HH; Liu YT; Lin L; Xing PY; Hao XZ; Cong MH; Wang HY; Wang Y; Li JL; Feng Y; Hu XS
    Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):416-424. PubMed ID: 35615798
    [No Abstract]   [Full Text] [Related]  

  • 38. Value of pretreatment serum lactate dehydrogenase as a prognostic and predictive factor for small-cell lung cancer patients treated with first-line platinum-containing chemotherapy.
    He M; Chi X; Shi X; Sun Y; Yang X; Wang L; Wang B; Li H
    Thorac Cancer; 2021 Dec; 12(23):3101-3109. PubMed ID: 34725930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does Adjuvant Chemotherapy for Locally Advanced Resectable Rectal Cancer treated with Neoadjuvant Chemoradiotherapy have an impact on survival? A Single Moroccan Institute Retrospective Study.
    Seddik Y; Brahmi SA; Afqir S
    Gulf J Oncolog; 2019 May; 1(30):29-32. PubMed ID: 31242979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver oligometastatic disease in synchronous metastatic gastric cancer patients: a nationwide population-based cohort study.
    Kroese TE; Takahashi Y; Lordick F; van Rossum PSN; Ruurda JP; Lagarde SM; van Hillegersberg R; Verhoeven RHA; van Laarhoven HWM
    Eur J Cancer; 2023 Jan; 179():65-75. PubMed ID: 36509000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.